U.S. health regulator the at the FDA turned down an application to approve Novartis‘ experimental heart failure drug due to insufficient evidence that it improves symptoms, Novartis said. Novartis said in […]
U.S. health regulator the at the FDA turned down an application to approve Novartis‘ experimental heart failure drug due to insufficient evidence that it improves symptoms, Novartis said. Novartis said in […]
Policies on our website
1.The content in this website should not replace and/or substitute the interactions with and advice you get from your healthcare professional, and if you have any concerns about your condition you should discuss these with your healthcare professional at the earliest opportunity.
2.This website uses cookies to improve your experience.